Elixinol has launched a new UK range of blended, full-spectrum CBD capsules using six original combinations developed to support good health and wellbeing.
Dr Christian Löfke, responsible for research and product development at BioBloom, walks us through the rudiments of essential oils as a potential modulator of the endocannabinoid system.
In this final article of a series of five, Oxford Cannabinoid Technologies will discuss their expertise on the use of cannabinoids in medicine when it comes to treating COVID-19.
Christian Hendriksen, VP of International Expansion at Mile High Labs, illustrates how they are continuing compliance with the novel food application to ensure safe and effective cannabinoids can be available to all.
Here, OilsBySimpson Founder Kevin William Simpson, explains what current research shows about CBD’s effect on epilepsy and its applications as a treatment.
Canna CBD Limited shares with us 12 ways you can take cannabidiol (CBD), including oils, tinctures, pills, edibles, as well as products for localised relief like bath salts, lotions, roll-ons and creams.
John Binns, Partner at BCL Solicitors LLP, provides us with fresh insight into COVID-19 and medical cannabis. He ponders if the crisis could bring opportunities for the industry.
A worldwide manufacturer and distributor of cannabinoid products, Elixinol are committed to creating the best organic hemp products for the mass market.
Liam McGreevy, CEO of Ethnopharm Ltd, explains his thoughts on creating value in today’s maturing cannabis market, including how the firm can help both new and established businesses make sense of this.
